This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Taro Chaya: Innovator in Retinal Health
Introduction
Taro Chaya is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of retinal health through his innovative research and inventions. His work focuses on improving and preventing symptoms related to the retina and light reception.
Latest Patents
Taro Chaya holds a patent for a medicament aimed at improving or preventing symptoms related to the retina and/or light reception. The patent describes a medicament that includes a substance capable of maintaining or enhancing the phosphorylation state of Unc119. Additionally, it outlines a method for screening substances that can improve or prevent these symptoms, specifically by selecting substances that inhibit calcineurin or activate casein kinase 2. This invention also includes agents for inhibiting retinal degeneration and protecting the retina, each comprising a substance that enhances the phosphorylation state of Unc119. He has 1 patent to his name.
Career Highlights
Taro Chaya is affiliated with Osaka University, where he conducts his research and development in the field of retinal health. His work has garnered attention for its potential impact on treating retinal conditions and improving light reception.
Collaborations
Taro Chaya collaborates with Takahisa Furukawa, a fellow researcher, to advance their shared goals in retinal health and innovation.
Conclusion
Taro Chaya's contributions to retinal health through his innovative patent demonstrate his commitment to improving medical treatments. His work at Osaka University continues to pave the way for advancements in this critical area of health.